Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Karenann Terrell appointed chief digital officer at GSK

Country: United Kingdom

Karenann Terrell, an electrical engineer and former executive at Walmart, is to join GlaxoSmithKline Plc on 4 September to help manage the pharmaceutical company’s use of digital technologies to improve performance.

Read more

FDA approves targeted drug for ALL

Country: United States

The US Food and Drug Administration has approved Besponsa (inotuzumab ozogamicin), an antibody-drug conjugate, to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).

Read more

GSK enters into second AI drug discovery deal

Country: United Kingdom

Read more

Overallotment exercised for Zealand Pharma’s IPO

Country: Denmark

Read more

Regeneron stops development of antibody for RSV

Country: United States

Read more

Zealand Pharma raises $78.3 million in Nasdaq IPO

Country: Denmark

Read more

Evotec continues to produce strong results

Country: Germany

Read more

Novo Nordisk increases sales of diabetes products

Country: Denmark

Read more

Positive data for Galapagos fibrosis drug

Country: Belgium

Read more

Profitability improves at Lundbeck

Country: Denmark

Read more

GW Pharma gives Epidiolex update

Country: United Kingdom

Read more

Embryo edits solve some problems, unleash new ones

Country: United States

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Medigene on a new course, interview with Dolores Schendel

Medigene Interview JulAug 2017.pdf

Highlights of the July-August 2017 MedNous issue

The July-August 2017 MedNous features:

Latest Mednous cover
  • Business Strategy
    Medigene on a new course
    Interview with Dolores Schendel
  • Research Strategy
    Using the accelerator and brake to treat cancer
    By Frédéric Triebel
  • Commentary
    The future of RNAi in the age of gene editing
    By Jonathan D Moore
  • Patient Advocacy
    Working with patients to accelerate drug development
    by Richard Goodfellow
  • Gene Editing
    The IP battle over CRISPR continues
    By John Dean
  • Stock Market Performance
    Evotec makes big gains

The latest MedNous journal. Subscribe to download.

Recent Appointments